Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	648.31M +88.8%
Revenue (ttm)	438.23K -69.5%
Net Income	-37.96M
EPS	-0.12
Shares Out	320.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142,165
Average Volume	203,491
Open	2.030
Previous Close	2.020
Day's Range	2.030 - 2.110
52-Week Range	1.115 - 2.250
Beta	0.28
RSI	56.47
Earnings Date	Feb 24, 2026

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to min...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2025, Imricor Medical Systems's revenue was $292,309, a decrease of -69.53% compared to the previous year's $959,424. Losses were -$25.32 million, -14.73% less than in 2024.

Financial numbers in USD